Innovative partnerships and financing strategies are critical to overcoming the unique challenges of developing malaria vaccines. We partner with government, academic, and industry experts to explore multiple vaccine concepts simultaneously and to advance the most promising candidates. We also work with partners to develop tools and processes needed to evaluate vaccine candidates. Our R&D strategy benefits from active engagement with the malaria community and our reliance on the best available data. Today, the world is closer than ever to developing a vaccine to defeat this parasitic disease.